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Background: Nanobodies (Nbs) have proved their great value as therapeutic molecules and clinical diagnostic
tools. Although the routine procedure to obtain Nbs is to immunize camels with antigens, it is unavailable to
immunize a camel when the antigens are highly toxic, pathogenic or nonimmunogenic. A synthetic phage display
library is an alternative to generate Nbs against such targets, besides all the other ones.
Methods: We constructed a large and diverse synthetic phage display Nanobody (Nb) library based on the
conserved camel single-domain antibody fragment (VHH) framework of cAbBCII10. Diversity was introduced in the
complementarity-determining region 3 (CDR3) by means of randomization of synthetic oligonucleotides. Then
human prealbumin (PA) and neutrophil gelatinase-associated lipocalin (NGAL) were used to select specific Nbs from
this library. Furthermore, a sandwich enzyme-linked immunosorbent assay (ELISA) was developed to detect PA
based on horseradish peroxidase (HRP)-conjugated anti-PA Nb isolated from this study and another biotinylated
anti-PA Nb obtained from an immune library, in our previous study.
Results: A large and diverse synthetic phage display Nb library with CDR3 regions randomized by trinucleotide
cassettes was constructed. The library size was 1.65 × 109 CFU/mL and the correct insertion ratio was nearly 100%. A
Nb against human PA and against NGAL was successfully isolated from the synthetic library. The obtained anti-PA
Nb was effectively used to develop a sandwich ELISA for PA detection and it demonstrated a working range from
50 to 1000 ng/mL, with a limit of detection (LOD) of 27.1 ng/mL.
Conclusion: This proposed novel synthetic library was a good source for obtaining some antigen-specific Nbs. This
approach could provide crucial support to an immune library and a naïve library in the acquisition of specific Nbs,
potentially functioning as a great resource for medical diagnostic applications. In addition, we have successfully
developed a novel sandwich ELISA to detect PA, which could provide great assistance for clinical PA detection.
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Since the technique of generation monoclonal antibodies
has been discovered, it has showed great value as both
diagnostic and therapeutic tool. Monoclonal antibodies
are mainly isolated from mouse hydridomas and can
recognize the antigens with high specificity and affinity.
The basic structure of a conventional immunoglobulin
G (IgG) molecule comprises two identical heavy chains
and two identical light chains linked together by inter-
chain of disulfide bonds. However, monoclonal antibodies
have some limitations. For example, the manufacturing
processes in the production capacity of therapeutic anti-
bodies in eukaryotic systems will cause a high cost [1].
Moreover, the large size of monoclonal antibodies may
disturb efficient tissue accessibility and penetration [2].
Such problems could be solved by obtaining smaller
antigen-binding antibody fragments [3].
With the rapid development of gene engineering tech-
niques, various recombinant antibody fragments, such as
antigen-binding fragment (Fab) and single-chain anti-
body fragment (scFv), have become promising alterna-
tives to monoclonal antibodies [4]. These antibody
fragments can maintain the specificity to antigens. More
importantly, they are amenable to feasible engineering
and of cheaper production as well as they possess some
unique properties for various diagnostic and therapeutic
applications [5]. A novel type of antibody fragment,
termed camel single-domain antibody fragments (VHH)
or Nanobody (Nb), is derived from heavy-chain anti-
bodies (HCAbs), which are present in sera of camelids
such as camels, llamas, alpacas and dromedaries [6].
With the average size of 15 kilodalton (kDa), Nanobodies
(Nbs) are the smallest naturally occurring integral antigen-
binding units [7].They are characterized by stringent mono-
meric performance, high stability, outstanding expression
yield in prokaryotic and eukaryotic hosts, and lower im-
munogenicity [8-10]. Thus, these properties make them
advantageous tools for biomedical applications [11-13].
Although camelids are large and outbreeding animals,
the process to induce HCAbs response in camelids are
identical to those used to elicit conventional antibodies
in other mammals. Cloning VHH genes and isolation of
Nbs from an immunized camelid is a simple and straight-
forward process. Phage display is the most popular
method for camelids Nb library construction. Nb libraries
generated from immunized camelids can maintain full
functional diversity. Although high affinity Nbs can be iso-
lated in a short period of time, in some cases it is difficult
to achieve, for example, when the immunization of camels
would be impossible due to a high toxicity or pathogen-
icity from the antigens, or in another instances if the
antigens would produced as inclusion bodies with wrong
folded proteins, self-immune antigens and some nonim-
munogenic small molecular compounds [14,15]. In orderto solve these problems, naïve or synthesized libraries
could be an alternative way [16]. Naïve libraries have been
reported in several studies with sizes within 1.6 × 105 to
5 × 109 colony-forming units (CFU)/mL [15,17-19]. In this
study, as shown in Figure 1, we have successfully con-
structed a synthetic phage display library by randomizing
the complementarity-determining region 3 (CDR3) of Nbs
by using a novel trinucleotide cassettes technology. The
size of the synthesized library is 1.65 × 109 CFU/mL with
great quality and diversity. After several rounds of bio-
panning, Nbs against human prealbumin (PA) and neutro-
phil gelatinase-associated lipocalin (NGAL) were isolated
and efficiently expressed, we termed them S-anti-PA Nb
and S-anti NGAL Nb, respectively. PA, a hepatic protein,
is especially sensitive to early phases of reduced nutrition,
particularly caloric intake and nitrogen balance [20,21], in
addition, the concentration of PA rapidly returns to nor-
mal values within the reference interval, once the malnu-
trition has been corrected [21]. Therefore, the assay of
circulating PA has revealed to be clinically valuable in the
evaluation of nutritional status, both as an initial screen
and in the monitoring of nutritional recovery [22]. NGAL
belongs to the lipocalin superfamily, which is found in
granules of neutrophils [23,24]. Several studies have shown
that NGAL is an early diagnostic biomarker for acute kid-
ney injury (AKI) in common clinical AKI scenarios includ-
ing contrast nephropathy, cardiac surgery, critical care and
transplantation [25-27]. Herein, by comparing the anti-PA
Nb from an immune library constructed in our previous
study [28] (we termed them I-anti-PA Nbs), the S-anti-PA
Nb showed comparable binding affinity and stability. In
addition, based on the use of S-anti-PA Nb coupled with
horseradish peroxidase (HRP) and I-anti-PA Nb48 conju-
gated with biotin, an enzyme-linked immunosorbent assay
(ELISA) method to detect PA was developed with a detec-
tion range from 50 to 1000 ng/mL with an acceptable cor-
relation coefficient (R2) of 0.9592 and a limit of detection
(LOD) of 27.1 ng/mL. All together, such a synthetic
library represents a good source for isolation of some
antigen-specific Nbs in some special cases, providing es-
sential support for both immune library and naïve library,




NGAL and PA were purchased from Huibiao Biological
Technology Co., Ltd. (China). HRP, goat alkaline phosphat-
ase (AP)-conjugated anti-mouse IgG, isopropyl β-D-1-thio-
galactopyranoside (IPTG), Bis (p-nitrophenyl) phosphate
(BNPP) and 3, 3′, 5, 5′-Tetramethylbenzidine (TMB) were
purchased from Sigma-Aldrich (USA). Mouse anti-HA tag
antibody was obtained from Covance (USA). Pst I, Not
I, Nco I and BstE II were obtained from NEB (USA).
Figure 1 Sketch map of strategies to construct the synthetic library, select the anti-PA and anti-NGAL VHHs, and detect PA using a
Sandwich-ELISA based on the isolated anti-PA Nb and another Nb derived from an immune library.
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Qiagen (Germany). Streptavidin (SA) Mutein Matrix was
purchased from Roche (Switzerland). Ultra-filtration col-
umn was purchased from Millipore (USA). Quick Gel
Extraction Kit was obtained from Axygen (China). 96-well
Maxisorp plate was purchased from Thermo Scientific
NUNC (Denmark). PBS, NaHCO3, H2SO4, NaIO4, NaBH4,
NaCl, MgCl2, tryptone, yeast extract, polyethylene glycol
(PEG) 6000, D-biotin, tween-20, bovine serum albumin
(BSA), ampicillin, kanamycin, imidazole, glycerol, ethylene
glycol and glucose were obtained from Sangon Biotech
(China). 24-well cell culture plate was purchased from
Corning (USA). BeaverNano™ SA Matrix Coated 96-Well
Plate was provided by Beaver (China). VCSM13 helper
phages, TG1 cells, WK6 cells, plasmids pBAD and pBirA
were provided by Serge Muyldermans (Laboratory ofCellular and Molecular Immunology, VUB-Vrije Universi-
teit, Brussel, Belgium). All aqueous solutions were prepared
with deionized water (DI water, 18 MΩ/cm, Milli-Q,
Millipore). Absorbance determination was performed on
Bio-Rad iMark™ (Bio-Rad, USA). Concentration measure-
ments of mRNA, DNA and protein were carried out with
Nano Drop 2000 (Thermo Scientific, USA). Optical dens-
ity (OD) determination was performed on UV-1800PC
spectrophotometer (Mapada, China). DNA was sequenced
by Nanjing Springen Biotechnology Co., Ltd.
Library construction
This antibody library was constructed based on an iden-
tified universal VHH framework of cAbBCII10 [29] with
synthetic diversity in CDR3. The diversity of CDR3 was
introduced by randomizing the library oligonucleotide
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means a 25% mix each of adenine, thymine, cytosine and
guanine nucleotides; and K stands for a 50% mix each of
thymine and guanine nucleotides) in the library DNA
construction with exactly sixteen amino acids (AA) but
cysteine (Cys) and stop codon-free. Determined DNA
sequence of cAbBCII10 framework region 1 (FR1)-
framework region 3 (FR3) was 5′-CAA GTT CAA TTG
GTT GAA TCT GGT GGT GGT TCT GTT CAA GCT
GG TGG TTC TTT GAG ATT GTC TTG TAC TGC
TTC TGG TGG TTC TGA ATAT TCT TAT TCT ACT
TTT TCT TTG GGT TGG TTT AGA CAA GCT CCA
GGT CAA GAA AGA GAA GCT GTT GCT GCT ATT
GCT TCT ATG GGT GGT TTG ACT TAT TAT GCT
GAT TCT GTT AAA GGT AGA TTT ACT ATT TCT
AGA GAT AAT GCT AAA AAT ACT GTT ACT TTGFigure 2 Construction of the synthetic library. (A) Schematic flow chart
universal VHH framework of cAbBCII10. Synthetic VHH genes were generat
Pst I and Not I, gel-purified sequentially and cloned into the phagemid vec
~ 300 bp with a determined DNA sequence of cAbBCII10 FR1-FR3 as the te
F-2 and R-2 as the amplification primers; Right. Final products assembled an
library measurement. Scraped colonies were diluted into 5 mL of PBS and 50
to estimate the correct insertion rate by performing PCR. (E) 30 clones were rCAA ATG AAT AAT TTG AAA CCA GAA GAT ACT
GCT ATT TAT TAT TGT GCT GCT-3′, which was used
to design primers for PCR amplification. The synthetic
nucleotides were assembled and amplified by overlapping
PCR extension, as illustrated in Figure 2A. The PCR-
related primers were: Forward primer-1 (F-1), 5′-CAT
ATG CAA GTT CAA TTG GTT GAA-3′; Reverse
primer-1 (R-1), 5′- AGC AGC ACA ATA ATA AAT -3′;
Forward primer-2 (F-2), 5′-ACT GCT ATT TAT TAT
TGT GCT GCT [N]16 TGG GGT CAA GGT ACT CAA-
3′; Reverse primer-2 (R-2), 5′-GAA TTC CTA AGA AGA
AAC AGT AAC TTG AGT ACC TTG ACC CCA-3′, as
displayed in Table 1. The final PCR products were
digested with Pst I and Not I and gel re-extracted using a
Quick Gel Extraction Kit. The purified PCR fragments
were cloned into the phagemid vector pMECS andfor the assembly of synthetic diversity in CDR3 based on an identified
ed by overlap PCR extension. Final PCR products were digested with
tor pMECS. (B) Left. F-1 and R-1 were used to amplify a fragment of
mplate; Middle. Agarose gel electrophoresis of the PCR products using
d amplified by overlapping PCR extension. (C) The capacity of the
μL were used to do gradient dilution. (D) 24 clones were randomly picked
andomly chosen for sequencing to detect the diversity of CDR3.
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cells. The VHH library was grown overnight at 28°C on
the plates containing solid 2 × tryptone and yeast extract
growth medium (2 × TY medium), which was supple-
mented with 100 μg/mL ampicillin and 2% (w/v) glucose.
The library capacity was measured by counting the num-
ber of colonies after gradient dilution. Meanwhile, 24 indi-
vidual clones were randomly chosen to determine the
correct insertion rate by PCR amplification and another
30 clones were sent for sequencing to determine the
amino acids distribution and composition of CDR3. Fi-
nally, colonies were scrapped from the plates and stored
in 2 × TY medium with 1% glucose and 50% (v/v) glycerol
at −80°C until further use.
Selection of anti-PA and anti-NGAL Nbs
500 μL of the library stock was grown in 100 mL of 2 ×
TY medium containing 100 μg/mL ampicillin, 70 μg/mL
kanamycin and 1% glucose. The cultures were grown at
37°C for 2.5 h and then 1 × 1012 VCSM13 helper phages
were added. After standing for 30 min at 25°C, the cells
were centrifuged at 3000 g for 10 min to recover, and
the bacterial pellets were added into 300 mL of 2 × TY
medium containing 100 μg/mL ampicillin and 70 μg/mL
kanamycin. The cultures were incubated at 37°C over-
night in a shaker. The VHH library was expressed on the
phages after infection with VCSM13 helper phages. The
phages were further precipitated with PEG 6000, 0.5 M
NaCl and dissolved in PBS. Afterwards, 100 μL of the
PBS solution containing 2 × 1011 phages were used in
screening on immobilized PA and NGAL coated on
96-well Maxisorp plate. Phages expressing anti-PA and
anti-NGAL VHHs were constantly enriched via several
consecutive rounds of panning. 95 randomly selected
individual colonies were cultured in terrific broth (TB)
medium containing 100 μg/mL ampicillin in 24-well
cell culture plates. The expression of Nbs was induced
with 1 mM IPTG followed by an incubation overnight.
Periplasmic extraction ELISA (PE-ELISA) was per-
formed to identify the E. coli TG1 colonies expressing
anti-PA and anti-NGAL Nbs. Finally, the positive colonies
were sequenced.
Expression and purification of isolated Nbs
Plasmids extracted from the positive colonies were electro-
transformed into E. coli WK6 cells. The recombinant Nbswere produced in shaker flasks by growing the cells in
330 mL of TB medium containing 100 μg/mL ampicillin,
2 mM MgCl2 and 0.1% glucose. 330 μL of IPTG (1 M)
was added into the medium when the OD 600 was be-
tween 0.6-0.9, then the cultures were grown for 16 h at
28°C. Periplasmic extracted proteins were released accord-
ing standard protocols [30]. The recombinant Nbs were
purified by NI-NTA Superflow Sepharose column, se-
quentially eluted with 100, 250 and 500 mM imidazole
solution. Protein purity was verified by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE),
and the eluted fragments were concentrated to 1 mg/mL
using Ultra-filtration column and dialyzed into PBS.
ELISA mapping of anti-PA and anti-NGAL Nb
The Nbs recognizing PA or NGAL were examined by
ELISA. Briefly, PA and NGAL were diluted into different
concentrations ranging from 0.1 to 20 μg/mL and coated
onto 96-well Maxisorp plates in 100 μL of NaHCO3
(0.1 M, pH 9.5) at 4°C overnight. After thorough wash-
ing with PBST (PBS with 0.05% Tween-20) for 3 times,
300 μL of 3% (w/v) BSA in PBS was added to each well
for blocking and incubated for 2 h at room temperature
(RT). The plates were washed 5 times with PBST before
the addition of 5 μg/mL Nbs followed by an incubation
of 1 h. After 5 washes, mouse anti-HA tag antibody (di-
luted 1:2000 in PBS) was added for 1 h at RT, and then
100 μL of goat AP-conjugated anti-mouse IgG diluted
1:2000 in PBS was added and incubated for 1 h at RT.
The catalytic reaction of AP was visualized by using BNPP
substrate. After 10–20 min, the readings at 405 nm were
measured with Bio-Rad imark™.
Comparison of reactive sensitivity to PA
The reactive sensitivity comparison between S-anti-PA
Nb, I-anti-PA Nb3 and I-anti-PA Nb48 was determined
by ELISA. 100 μL of PA (5 μg/mL in 0.1 M NaHCO3,
pH 9.5) was coated onto 96-well Maxisorp plate overnight
at 4°C. 100 μL of the exactly same NaHCO3 solution was
used as the coating buffer as control. Non-specific binding
sites were blocked by 3% (w/v) BSA in PBS for 2 h, the
three Nbs were diluted to the same concentration from
0.001 to 10 μg/mL, and were added to the wells followed
by incubation for 1 h at RT. The following steps were the
same as that described above in ELISA mapping.
Thermostability analysis
Thermostability was analyzed by ELISA. S-anti-PA Nb,
I-anti-PA Nb3 and I-anti-PA Nb48 were diluted to
1 mg/mL in PBS and incubated at 37°C for 0, 2, 12, 24,
48, 60 and 72 h. After incubation, the Nbs were diluted
to a final concentration of 10 μg/mL before adding to an
ELISA plate coated with 10 μg/mL PA. The rest steps
were same as that described above in ELISA mapping.
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To determine whether the S-anti-PA Nb and I-anti-PA
Nbs can recognize the different antigen epitopes, HRP was
used to couple to the Nbs. Briefly, 100 μL of fresh NaIO4
(0.1 M) was incubated with 200 μL of 5 mg/mL HRP solu-
tion for 30 min at 4°C. Next, 100 μL of 2.5% (v/v) ethylene
glycol were added and incubated for 30 min at RT. Then
1 mL of PA-specific Nbs (1 mg/mL) was added and 1 M
CB (carbonate and bicarbonate) solution (pH 9.5) was
used to adjust the pH to about 9.0, then the mixture was
incubated at 4°C overnight in the dark. Afterwards, 20 μL
of NaBH4 (5 mg/mL) were mixed into for 3 h at 4°C and
finally, the mixture was transferred to Ultra-filtration
column to replace the buffer with PBS.
Assessment of Nbs binding to distinct epitopes on PA
Epitope sharing between the anti-PA Nbs was investi-
gated by a competition ELISA. For this purpose, 96-well
Maxisorp plate was coated with 100 μL of 10 μg/mL
Nbs in NaHCO3 (0.1 M, pH 9.5) at 4°C overnight. After
washing with PBST and blocking with 3% BSA, 100 μL
of PA (2 μg/mL) was added to the PA-coated wells and
PBS without PA was added into the corresponding wells
as the control. After 1 h, 5 different Nbs coupled with
HRP (2 μg/mL) were added to each Nb-coated well.
After extensive washes by PBST, 100 μL of TMB solu-
tion was added and incubated for 5–10 min at RT. The
enzyme reaction was stopped by adding 50 μL of 2 M
H2SO4 and the absorbance was read at 450 nm.
Nb biotinylation
The biotinylation of Nb was performed according to our
previous studies [31]. Briefly, genes encoding I-anti-PA
Nb48 were sub-cloned into plasmid pBAD17 by using
Nco I and BstE II as restriction sites and the recombin-
ant plasmid was co-transformed into WK6 cells with
plasmid pBirA. The cells were cultured in TB medium
and induced with 1 mM IPTG to express proteins
followed by the addition of 50 μM biotin. Biotinylated I-
anti-PA Nb48 (BiNb48) was purified by SA Mutein Matrix
with 6 mM biotin elution buffer. The residual biotin mole-
cules were removed by Ultra-filtration column with PBS
for several times.
PA detection by ELISA based on biotin-SA interaction
100 μL of BiNb48 (1 μg/mL) in PBST were coated on
BeaverNano™ SA Matrix Coated 96-Well Plate at RT for
1 h. After washing with PBST for 5 times and blocking with
5% BSA for 1 h, the wells were incubated with serial
dilutions (0, 1, 5, 10, 50, 100, 250, 500, 750, 1000, 2000 and
3000 ng/mL) of PA for 2 h. 100 μL of S-anti-PA Nb
coupled with HRP (S-anti-PA Nb-HRP) (1 μg/mL) in PBST
containing 5% BSA was added. The rest of the experiment
was performed as described above in epitope mapping.Results
Construction of a synthetic phage display Nb library
cAbBCII10 has been proved to be an excellent candidate
as an universal framework based on its good stability,
good expression level and functional property in the
absence of the conserved disulfide bond [29]. Herein,
overlapping PCR approach was used to orderly link all
oligonucleotides (Figure 2A). The library diversity was
dependent on the diverse composition of AA in the
CDR3. Assembly PCR was performed with primers listed
in Table 1. Individual PCR products were checked by
agarose gel as shown in Figure 2B. A total of 50 electro-
transformations were performed to obtain satisfactory
diversity and the final library was calculated to contain
about 1.65 × 109 independent clones (Figure 2C). PCR
analysis revealed that 100% of randomly picked clones
have been correctly inserted (Figure 2D). Meanwhile, the
AA distribution and composition in CDR3 was in good
agreement with the designed pattern. Neither stop
codon nor Cys was observed in all 30 clones (Figure 2E),
which indicated a randomization has been successfully
achieved. Most importantly, among these 30 clones,
CDR3 showed high diversity, only two of them (Clone 1
and Clone 2) shared the same AA sequence (Figure 2E).
Bio-panning of synthetic library against PA or NGAL
The synthetic library was used to panning against PA
and NGAL. To calculate the enrichment during the
course of screenings, we compared the ratio of colony
number between PA or NGAL and NaHCO3 (0.1 M,
pH 9.5) control. As shown in Figure 3A, the ratio was
increased to 20 after the sixth round for PA and in-
creased to 18 for NGAL, respectively. Total 15 positive
colonies for PA and 54 positive colonies for NGAL with
a binding ratio more than 2 have been identified (data
not shown). After sequence analysis, the 15 anti-PA
clones were classified as one Nb and the 54 anti-NGAL
clones were also classified as one Nb as they exhibited
the same AA sequence in CDR3. The AA sequences of
the two Nbs did not show Cys as expected (Figure 3B).
In our previous study, we isolated several anti-PA Nbs
from an immune library, which were successfully used
to develop a Nb-based flow injection chemiluminescence
immunoassay for sensitive detection of PA [28]. The AA
sequence comparison demonstrated that they did not
share any sequence similarity in CDR3 (Figure 3B).
Production of soluble Nbs and ELISA mapping
In order to express the isolated Nbs, the phagemid
pMECS was transformed into E. coli WK6 cells. These
cells have specific properties which cannot suppress the
amber stop codon between VHH and the gene III in
phagemid pMECS. The induced Nbs were extracted
from the periplasmic parts and sequentially eluted with
Figure 3 Selection of anti-PA and anti-NGAL Nbs. (A) Enrichment exhibition of six rounds by panning. The histogram shows the enriching
times for every round of panning. (B) The complete AA sequence of selected S-anti-PA Nb and S-anti-NGAL Nb and the CDR3 AA sequence of
three I-anti-PA Nbs selected from the immune library.
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lysis demonstrated that the purity of Nbs reached 90%,
and the production of S-anti-NGAL Nb was much
higher than S-anti-PA Nb (Figure 4A). To identify the
binding specificity after the pure Nbs were successfully
isolated, indirect ELISA was performed to detect the
specific interaction between the Nbs and antigens. With
the increased concentrations of PA and NGAL, the bind-
ing ratio relative to BSA (negative control) was also
increased (Figure 4B).
Nb reactivity to PA by ELISA assay and thermostability
analysis
To further explore whether the S-anti-PA Nb as good as
the I-anti-PA Nb3 and I-anti-PA Nb48 in some features,
we compared the Nbs’ reactivity to PA and thermostability.
In pMECS, the products of Nb contain both a hexahisti-
dine (His6) and hemagglutinin (HA) tag at the C-terminus.
His6 was used as the affinity tag for the Nbs purification
and HA tag provided convenience for the Nbs detection
in ELISA. For reactivity comparison, when the 96-well
Maxisorp plate was coated with PA, at a concentration of
0.01 μg/mL, the S-anti-PA Nb still showed ability to bind.
However, we observed that I-anti-PA Nb3 and I-anti-PA
Nb48 could bind with PA even at a lower concentration of
0.005 μg/mL, the binding activity of S-anti-PA Nb was
weaker (Figure 5A). In addition, we checked the stability
of anti-PA Nbs under heat treatment at 37°C for different
incubation time intervals. As shown in Figure 5B, aftertreatment for 24 h, the S-anti-PA Nb and the two I-
anti-PA Nbs could still keep nearly 80% of their binding
activity. Similarly, the S-anti-PA Nb displayed lower
thermostability with only 20% activity in comparison
with 58% activity of the I-anti-PA Nb3 and 68% activity
of the I-anti-PA Nb48, after treatment for 48 h. Add-
itionally, after an incubation for 72 h, the S-anti-PA Nb
showed almost no activity, however, the two I-anti-PA
Nbs still demonstrated about 19% activity (Figure 5B).
Assessment of Nbs binding to distinct epitopes on PA
We are motivated to test whether the synthetic library-
derived Nbs would be promising for further diagnostic
applications. As we have isolated two Nbs respectively
against PA and NGAL in this study as well as we have
obtained three anti-PA Nbs from an immune library in
our previous study (Ma et al. [28]), it is interesting to
determine whether one of the three I-anti-PA Nbs that
could recognize a unique epitope of PA different than
the one recognized by the S-anti-PA Nb, which could
provide a potential to develop a sandwich ELISA for the
detection of PA. By performing the paired experiment,
only I-anti-PA Nb48 was identified.
Nb biotinylation
According to the results of epitope mapping (data not
shown), I-anti-PA Nb48 was chosen to be conjugated
with biotin in vivo as the capture protein used in the PA
detection by ELISA. In order to perform the Nb
Figure 4 Nbs purification and ELISA mapping of the purified Nbs. (A) The recombinant Nbs were orderly eluted with 100, 250 and 500 mM
imidazole solution, and the purity was verified by SDS-PAGE. (B) ELISA mapping of PA-specific Nb and NGAL-specific Nb using different PA and
NGAL concentrations ranging from 0.1 to 20 μg/mL. Three independent experiments were performed.
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plasmid pBAD17 that contains a biotin acceptor domain
and the recombinant plasmids were co-transformed into
WK6 cells with another plasmid pBirA to express biotin-
conjugated I-anti-PA Nb48. BiNb48 was analyzed by SDS-
PAGE (Figure 6A) and it was produced at a final yield of
1 mg/mL culture.
PA detection by ELISA based on biotin-SA interaction
As shown in Figure 1, BiNb48 were directionally cap-
tured by SA coated on BeaverNano™ SA Matrix Coated
96-Well Plate. After PA was recognized and captured by
BiNb48, S-anti-PA Nb-HRP was used as the detector.
The absorbance at 450 nm displayed a good linearity with
the concentrations of PA in the range from 50 to 1000 ng/
mL. The linear equation was calculated as Y = 0.0005 X +
0.3726 with an acceptable R2 of 0.9592 (Figure 6B), andthe LOD was 27.1 ng/mL, illustrating a strong application
value of this method for PA detection.
Discussion
Immunization of camels with various antigens is as
straightforward as other animals. However, if the antigens
are toxic, of low immunogenicity, limited availability, or
nonimmunogenic compounds, immunization will not be
feasible for all animals. Such circumstances impose great
challenges for the conventional antibody production.
Phage display recombinant antibodies could solve these
problems by constructing naïve or synthetic libraries with
high diversity. Owing to the technical limitations, the
maximum size of naïve or synthetic libraries is 8 ×
109 CFU/mL [32-35]. Based on a split-mix-split method,
a synthetic human scFv antibody library with random-
ized CDR3 was successfully constructed and applied for
Figure 5 Comparison of the reactive sensitivity to PA and
thermostability analysis of two libraries-derived anti-PA Nbs.
(A) Indirect ELISA was used to compare the reactive sensitivity to PA
with different gradient concentrations of anti-PA Nbs ranged from
0.001 to 10 μg/mL. The error bars represent the standard deviation
derived from three independent experiments. (B) Thermostability
analysis of two libraries-derived anti-PA Nbs. Three Nbs stayed at 37°C
for 0, 2, 12, 24, 48, 60 and 72 h were used to perform ELISA. The activity
of Nbs never stayed under 37°C was regarded as 100%. Three
independent experiments were performed.
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anti-ovarian carcinoma bispecific antibody) [36]. Naïve
phage display Nb libraries have also been reported in
several studies [15,37]. Although there is no affinity mat-
uration step like in vivo immunization, it is still possibleFigure 6 Detection of PA by a sandwich ELISA based on BiNb48 and th
solution and analyzed by SDS-PAGE. (B) Calibration curve for PA detection. Thto obtain high affinity Nbs with picomolar affinity [15,37].
However, affinity is also dependent on antigen properties.
Subsequent and time-consuming in vitro maturation steps
can improve affinity [14,15,38]. Phage-displayed Nbs from
immune or naïve libraries are made from a natural source
of blood. The large sequence diversity in these libraries
leads to a large variability in stability, expression level and
physical properties. However, in vitro approach allows the
construction of libraries built on a selected limited set of
sequences leading to more consistent and optimized char-
acteristics. Although their lower structural diversity, it is
possible to obtain Nbs with high specificity and affinity
against any antigen from such libraries. In this study, we
chose cAbBCII10 as a universal VHH framework. cAbB-
CII10 has proved to be a great framework based on its
high stability and good expression than the original VHH.
Additionally, it is serviceable in the absence of the
conserved disulfide bond of the immunoglobulin fold or
under reducing conditions, which is a prerequisite for
intrabody applications [29]. In order to get great diversity
and high quality synthetic Nb library, we introduced
random sequence in the CDR3 using degenerate synthetic
oligonucleotides. The diversity of natural Nb is mainly due
to the sequence variability in the CDR3 and restraining
the diversity to this region is sufficient to generate greatly
efficient and diverse libraries.
Herein, the random sequences in CDR3 were random-
ized using trinucleotide cassettes of bacterial preference,
which could completely avoid stop and non-sense codons.
In addition, the trimer codons for Cys were excluded.
After 50 times of high efficiency of transformation, the
current size of our library is 1.65 × 109 CFU/mL, which
classified as a considerable large library. The overall library
size is an important factor for obtaining high affinity
clones. As validated by sequencing, almost 100% of ran-
domly picked colonies contained the correct sequences
and none Cys or stop codon was found as expected, which
meant the functional capacity of the library was also verye HRP-coupled S-anti-PA Nb. (A) BiNb48 was eluted into 6 mM biotin
e linear relationship was in the range from 50 to 1000 ng/mL.
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completely absent. However, as it is a synthetic library, as
opposed to a naïve library or immune library, it may show
to be less functional as they have not been through a
natural in vivo selection for functionality or affinity matur-
ation [39]. As a consequence, the Nbs isolated from the
synthetic library were not exactly as good as that isolated
from the immune library in our study. Yet we cannot
exclude the possibility that the weaker binding activity and
stability of Nbs from the synthesized library is target by
target situation. It will be highly possible to isolate Nbs
with high affinity and good stability by screening more
antigens. Nevertheless, the production of Nbs in E. coli is
at low cost, it is acceptable to apply the synthetic library-
derived Nbs for further diagnostic applications.
We have successfully isolated three Nbs against PA
from an immune library with high specificity and affinity
in our previous study [28]. Among them, Nb48 recognized
a different epitope of PA from that S-anti-PA recognized.
Based on the biotin-SA interaction, the S-anti-PA Nb
coupled with HRP was used as the detector and the I-anti-
PA Nb48 conjugated with biotin was used as the capture
protein to detect PA. A linear relation between the absorb-
ance at 450 nm and the concentration of PA was observed
in a range from 50 to 1000 ng/mL with a R2 of 0.9592,
and the LOD is 27.1 ng/mL. The relatively broad consen-
sus reference range of PA for an adult is 120–500 mg/L
[22]. Several studies [40,41] have recommended that a
concentration of <110 mg/L is high risk, a chief nutritional
therapy is necessary; 110–170 mg/L is considered moder-
ate risk, requiring less serious nutritional therapy; and
>170 mg/L is of little or no risk. Therefore, reference
range values of PA represent a high range for any assay.
According to the reference range for PA and the working
range we obtained in this study, the samples need to be di-
luted about 1000-fold before being determined. Therefore,
it just needs small amount of serum sample from the
patients. The reported methods for determining PA
are mainly electrophoresis [42], radioimmunoassay [43],
immunonephelometric assays [44], radial immunodiffu-
sion [45], nanogold-labeled immunoresoance scattering
spectral assay [46] and ELISA [47]. Electrophoresis ana-
lysis has better sensitivity, but it costs long time and it
could not assay massive samples at the same time [42].
The relativity of radioimmunoassay is good, but owing to
the half-life of isotope, the results are unstable [43].
Immunonephelometric assays were used to measure PA
with a working range 1–3 mg/L [44]. Its detection range
was not in an order of magnitude with that in this study,
as we used an ELISA that its working concentration could
not be such high. Radial immunodiffusion is also time-
consuming. A nanogold-labeled immunoresoance scatter-
ing spectral assay was used to determine 16.67-666.67 ng/
mL PA with LOD of 4 ng/mL [46], which was lower than27.1 ng/mL. However, the process of this assay is a little
tedious and it needs more than one special apparatus.
Comparatively, ELISA is a simple, straightforward and
relatively sensitive approach. An ELISA method based on
peroxidase-labeled antibody was used, with a linear range
of 1–4 ng per well [47]. According to the reaction volume
in the ELISA system, the working range is about 10–
40 ng/mL, which was much narrow than 50–1000 ng/mL.
Although the LOD in our study is not very low, in consid-
eration to the reference range of PA under different nutri-
tional conditions, it is enough for real PA detection after
the patients’ serum samples are diluted 1000-fold, and it
needs a very small amount of serum sample, which is
more acceptable for the patients.
All together, the trinucleotide cassette-randomized li-
brary will be a good source for isolation of some antigen-
specific Nbs, which could provide critical support for an
immune library or a naïve library. In fact, numerous phage
display libraries have been created with many diverse
specialized characteristics [48-51] over the past years, the
creation of new libraries continues as knowledge develop-
ment and technology expands.
Conclusion
In this study, we constructed a large synthetic phage dis-
play Nb library based on the conserved VHH framework
of cAbBCII10 and diversity was introduced in the CDR3
by randomizing synthetic trinucleotide cassettes. Then
Nb against PA or NGAL was successfully selected from
this library. Further a sandwich ELISA was fabricated to
detect PA with a detection range from 50 to 1000 ng/
mL and a detection limit of 27.1 ng/mL based on the
HRP-coupled anti-PA Nb obtained from this study and
another biotinylated anti-PA Nb isolated from an im-
mune library in our previous study. Thus, this proposed
novel synthetic library could provide crucial support
to immune library or naïve library in acquirement of
specific Nbs, potentially functioning as a great resource
for medical diagnostic applications. In addition, we have
successfully developed a novel sandwich ELISA to detect
PA with a relatively low LOD and wide working range,
which is an alternative for the clinically tracing of PA.
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